ArticleMolecular and cellular biochemistry2020

Substance P receptor blocker, aprepitant, inhibited cutaneous and other neurogenic inflammation side effects of the EGFR1-TKI, erlotinib.

Joanna J Chmielinska et al.PubMed ↗Publisher ↗

No numbers read from the abstract.